- This event has passed.
Expert Series: Simplifying the Mitochondrial Medication Experience Through Compounded Mito Cocktails
June 5 @ 12:00 pm – 1:00 pm EDT
As the incidence of mitochondrial disease continues to rise, patients having a better understanding surrounding their therapies remains critical. Compounding pharmacies play a key role in simplifying medication regimens while providing affordable options. This presentation will explore the importance of compounding pharmacies while highlighting how ACHC rare disease accredited compounding pharmacies employ clinical teams that support both patients and clinicians during their treatment journey.
About the Speaker
Houry Lepedjian
Houry Lepedjian, our VP of Operations, is a trilingual Pharm D, who has been with Chemistry Rx since 2016. Houry began her tenure as an intern and then a staff pharmacist, where she became passionate about servicing rare disease patients and patients suffering from chronic debilitating conditions. Houry has an in depth understanding of Mitochondrial disease and works closely with our Director of Lab, formulating the appropriate dosage forms based on their condition. She also oversees the clinical nursing team as they work to establish insurance coverage. Houry was instrumental in Chemistry Rx becoming the only ACHC Rare Disease Accredited compounding pharmacy and ensures that our clinical team remains committed to being an ally to the diverse patient population we service. As a multilingual pharmacist, she works directly with many embassies that oversee treatments in genetic treatment centers serviced by Chemistry Rx. In her 8 years with Chemistry Rx, Houry has watched the Folcroft facility grow from 6 employees to over 50 employees, and overseas operations in our nationally licensed 503A compounding facility located in Folcroft PA. She is personally licensed in a total of 18 states and ensures that quality and regulations which pertain to patient safety remain paramount to the operation. In her free time, she enjoys spending time with her 2 young children, husband and furthering her education, as she is an MBA candidate at Temple University.
Jonathan Mordis, CEO
Jonathan Mordis is CEO of the Chemistry RX platform, which includes four 503A compounding pharmacies throughout the USA. Jonathan is a 3rd generation pharmacist who has practiced in many different aspects of pharmacy throughout his career. In 2011, he became immersed in compounding pharmacy services after witnessing the struggles many patients experienced when they suffered from rare and debilitating conditions, and those for which commercially available products did not provide adequate therapies for. He joined Chemistry RX in 2022 as COO and moved into the CEO role later that year. His pharmacy knowledge includes clinical patient care, pharmacy operations, and provider and institutional hospital business development. Jonathan brings his mission of “no patient left behind” to every organization he has ever been a part of. This mission allows him to build teams that provide superior benefit to critically ill patients and allows these patients to not be burdened with the logistics and availability of the best treatments for their conditions. In his free time, he enjoys exercising, the outdoors, and spending time with his 3 kids.
Bryan R. Cohen, BSN, RN
Bryan R. Cohen, BSN, RN is the Clinical Nurse Manager at Chemistry Rx Compounding and Specialty Pharmacy, where he has worked for 5 years. He manages a team of nurses who coordinate with providers on the insurance coverage process for and educate patients and families on compounded medications. Prior to entering the compounding world, his experience was on the opposite side of the pharmaceutical industry, answering calls for manufacturers about their commercially available medications. Outside of work, he is a songwriter/composer and lives in Abington, PA with his two cats.
